Biotech Biohaven has signed a non-dilutive funding deal with Oberland Capital as it awaits an FDA ruling on its ...

EPS estimates, maintains 2025 guidance, and targets $5.7 billion in cost savings through automation and R&D streamlining.

Pfizer has several products with fast-rising sales. Nurtec ODT and Padcev especially stand out. Its pipeline is also promising: 115 programs in clinical development, 32 of which are in late-stage ...

The Department of Justice (DoJ) claims that Biohaven – before being acquired by Pfizer – paid "improper remuneration" to some Nurtec ODT (rimegepant) prescribers in the form of speaker fees ...

Qulipta currently has no reports of interacting with Nurtec, better known as Nurtec ODT (rimegepant). Both Qulipta and Nurtec ODT belong to a group of drugs called CGRP antagonists. Both drugs ...